Filtered By:
Specialty: Biomedical Science
Vaccination: Influenza Vaccine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 22 results found since Jan 2013.
Effects of COVID-19 and Influenza Vaccination on Rheumatic Diseases: Results From a Survey of Patient-Reported Outcomes After Vaccination
CONCLUSION: The results of the survey of patients with ARD revealed that patient-reported AEs and underlying disease flares after receiving the COVID-19 vaccine were significantly higher than those after the influenza vaccine.PMID:37582497 | DOI:10.3346/jkms.2023.38.e247
Source: Journal of Korean Medical Science - August 15, 2023 Category: Biomedical Science Authors: Ji-Won Kim Ju-Yang Jung Chang-Hee Suh Young-Min Ye Hyoun-Ah Kim Source Type: research
Psychological and Personality Characteristics Associated With COVID-19 Vaccination Behavior in Korean General Population
CONCLUSIONS: People weighed the benefits of COVID-19 vaccination against the risk of side effects when deciding to receive the COVID-19 vaccine. Our findings also indicate that this vaccination behavior may be affected by coping mechanisms and psychological factors.PMID:37527911 | PMC:PMC10396430 | DOI:10.3346/jkms.2023.38.e234
Source: Journal of Korean Medical Science - August 1, 2023 Category: Biomedical Science Authors: Seunghyong Ryu Ju-Wan Kim Ju-Yeon Lee Young-Shin Kang Hee-Young Shin Sook-In Jung Jae-Min Kim Sung-Wan Kim Source Type: research
Impact of antigenic evolution and original antigenic sin on SARS-CoV-2 immunity
Infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and vaccinations targeting the spike protein (S) offer protective immunity against coronavirus disease 2019 (COVID-19). This immunity may further be shaped by cross-reactivity with common cold coronaviruses. Mutations arising in S that are associated with altered intrinsic virus properties and immune escape result in the continued circulation of SARS-CoV-2 variants. Potentially, vaccine updates will be required to protect against future variants of concern, as for influenza. To offer potent protection against future variants, these second-generati...
Source: Journal of Clinical Investigation - January 4, 2023 Category: Biomedical Science Authors: Muriel Aguilar-Bretones, Ron A.M. Fouchier, Marion P.G. Koopmans, Gijsbert P. van Nierop Source Type: research
Plantaricin NC8 αβ rapidly and efficiently inhibits flaviviruses and SARS-CoV-2 by disrupting their envelopes
In this study, we have tested the antiviral effects of PLNC8 αβ against the flaviviruses Langat and Kunjin, coronavirus SARS-CoV-2, influenza A virus (IAV), and human immunodeficiency virus-1 (HIV-1). The concentration of PLNC8 αβ that is required to eliminate all the infective virus particles is in the range of nanomolar (nM) to micromolar (μM), which is surprisingly efficient considering the high content of cholesterol (8–35%) in their lipid envelopes. We found that viruses replicating in the endoplasmic reticulum (ER)/Golgi complex, e.g. SARS-CoV-2 and flaviviruses, are c onsiderably more susceptible to PLNC8 αÎ...
Source: PLoS One - November 30, 2022 Category: Biomedical Science Authors: Abubakr A. M. Omer Source Type: research
Determinants of acceptance of Coronavirus disease-2019 (COVID-19) vaccine among Lebanese health care workers using health belief model
This study aimed to assess the acceptance rate of the COVID-19 vaccine among HCWs and to identify its determinants. A web-based cross-sectional study was conducted between10 and 31 D ecember 2020 among Lebanese HCWs. The Health Belief Model (HBM) was used as a theoretical framework. Multivariable logistic analyses were carried out to identify the factors associated with the acceptance of the COVID-19 vaccine among HCWs. A total of 1800 HCWs have completed the survey. Around half (58.10%) of them were frontline HCWs and aged between (30–49) years old. Over two-thirds (67.33%) of the participants have received the seasonal...
Source: PLoS One - February 22, 2022 Category: Biomedical Science Authors: Dalal Youssef Source Type: research
Dermatomyositis Following BNT162b2 mRNA COVID-19 Vaccination
J Korean Med Sci. 2022 Feb 7;37(5):e32. doi: 10.3346/jkms.2022.37.e32.ABSTRACTDermatomyositis (DM) is one of the uncommon multi-organ idiopathic inflammatory myopathies that has been reported following the hepatitis B, Influenza, tetanus toxoid, H1N1, and BCG vaccines. However, an association with the coronavirus disease 2019 (COVID-19) vaccine is yet to be reported. In this case, we present the case of a 43-year-old Asian Indian female who was diagnosed with DM 10 days after receiving the second dosage of BNT162b2 mRNA COVID-19 vaccination, in the absence of any additional triggering factors. The diagnosis was established...
Source: Journal of Korean Medical Science - February 8, 2022 Category: Biomedical Science Authors: Wesam Gouda Anwar Albasri Faisal Alsaqabi Humoud Y Al Sabah Marwan Alkandari Hassan Abdelnaby Source Type: research
